Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Insurance Press Releases.
Press releases published on September 5, 2025

Gyre Therapeutics to Present at the H.C. Wainwright 27th Annual Global Investment Conference
SAN DIEGO, Sept. 05, 2025 (GLOBE NEWSWIRE) -- Gyre Therapeutics (“Gyre”) (Nasdaq: GYRE), an innovative, commercial-stage biopharmaceutical company dedicated to advancing fibrosis-first therapies across organ systems affected by chronic disease, today …

GSR IV Acquisition Corp. Announces the Closing of its $230 Million Initial Public Offering, Including Full-Exercise Of Over-Allotment Option
New York, NY, Sept. 05, 2025 (GLOBE NEWSWIRE) -- GSR IV Acquisition Corp. (NASDAQ: GSRF) (“GSRF” or the “Company”) announced today that it closed its initial public offering of 23,000,000 units at a price of $10.00 per unit, for aggregate gross proceeds of …

Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
NEW YORK, Sept. 05, 2025 (GLOBE NEWSWIRE) -- Syndax Pharmaceuticals (Nasdaq: SNDX), a commercial-stage biopharmaceutical company advancing innovative cancer therapies, today announced that on September 1, 2025 the Company granted inducement awards to …

Adverum Biotechnologies Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
REDWOOD CITY, Calif., Sept. 05, 2025 (GLOBE NEWSWIRE) -- Adverum Biotechnologies, Inc. (Nasdaq: ADVM) today announced that the Compensation Committee of Adverum’s Board of Directors granted inducement awards consisting of non-qualified stock options to …

aTyr Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
SAN DIEGO, Sept. 05, 2025 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: ATYR) (“aTyr” or “the Company”), a clinical stage biotechnology company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase …

Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
WESTLAKE VILLAGE, Calif., Sept. 05, 2025 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, today reported the grant of an …

Purple Biotech Announces Closing of Up To $18 Million Public Offering $6 million upfront with up to an additional $12 million of potential aggregate gross proceeds upon the exercise in full of short-term warrants
REHOVOT, Israel, Sept. 05, 2025 (GLOBE NEWSWIRE) -- Purple Biotech Ltd. (“Purple Biotech” or “the Company”) (NASDAQ/TASE: PPBT), a clinical-stage company developing first-in-class therapies that seek to overcome tumor immune evasion and drug resistance, …

Spring Valley Acquisition Corp. III Announces Closing of $230 Million Initial Public Offering
DALLAS, Sept. 05, 2025 (GLOBE NEWSWIRE) -- Spring Valley Acquisition Corp. III (the “Company”), a blank check company formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business …

Aristotle Receives CFTC Approval for DCM and DCO, Paving the Way for New U.S. Prediction Market Exchange
WASHINGTON, Sept. 05, 2025 (GLOBE NEWSWIRE) -- Aristotle, the company that services PredictIt, today announced that the Commodity Futures Trading Commission (CFTC) has approved its applications to operate as both a Designated Contract Market (DCM) and a …

Blink Charging President and CEO, Mike Battaglia, to Present at the H.C. Wainwright 27th Annual Global Investment Conference on Tuesday, September 9, 2025
Bowie, MD, Sept. 05, 2025 (GLOBE NEWSWIRE) -- Blink Charging Co. (NASDAQ: BLNK), a leading global owner, operator, provider of electric vehicle (EV) charging equipment and services, today announced that Mike Battaglia, President and CEO, will present at …

DIAGNOS Announces Closing of Private Placement
BROSSARD, Quebec, Sept. 05, 2025 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK, OTCQB: DGNOF, FWB: 4D4A), a pioneer in early detection of critical health issues using advanced technology based on Artificial …

Pixalate Releases Q2 2025 Global Connected TV (CTV) Ad Supply Chain Trends Reports: Open Programmatic Ad Spend at $5.7 Billion While Ad Fraud (IVT) Remained at 18%
LONDON, Sept. 05, 2025 (GLOBE NEWSWIRE) -- Pixalate, the leading ad fraud protection, privacy, and compliance analytics platform, today released the Q2 2025 Global Connected TV (CTV) Ad Supply Chain Trends Report. The report comprehensively analyzes the …

U.S. Global Investors Announces Fiscal 2025 Webcast
San Antonio, TX, Sept. 05, 2025 (GLOBE NEWSWIRE) -- U.S. Global Investors, Inc. (Nasdaq: GROW) will host a webcast on Tuesday, September 9, at 7:30 a.m. Central time to discuss the company’s results for fiscal year 2025. Financial data for the fiscal year …

Replimune (REPL) Faces Investor Lawsuit After FDA Blocks Cancer Drug Approval - Hagens Berman
SAN FRANCISCO, Sept. 05, 2025 (GLOBE NEWSWIRE) -- Replimune Group Inc. (NASDAQ: REPL) is under fire from investors following a dramatic regulatory setback that sent its stock into freefall. A newly filed securities class action accuses the biotech firm and …

SuperX AI (SUPX) Stock Plunges Amid Allegations of AI Washing -- Hagens Berman
SAN FRANCISCO, Sept. 05, 2025 (GLOBE NEWSWIRE) -- Shares of SuperX AI Technology Limited (NASDAQ: SUPX) plunged more than 24% in intraday trading on September 5, 2025, after short-seller J Capital Research released a scathing report alleging the company is …

All Talentz Showcases Outsourcing Excellence at GITEX Nigeria 2025
LAGOS, Nigeria, Sept. 05, 2025 (GLOBE NEWSWIRE) -- All Talentz LLC, a U.S.-headquartered outsourcing and workforce solutions company, proudly participated in GITEX Nigeria 2025, hosted at the Eko Hotel, Victoria Island, Lagos. The event, which brought …

Nutex Health (NUTX) Faces Investor Lawsuit Over Alleged Revenue Inflation Scheme-- Hagens Berman
SAN FRANCISCO, Sept. 05, 2025 (GLOBE NEWSWIRE) -- Nutex Health Inc. (NASDAQ: NUTX), a publicly traded operator of micro-hospitals and healthcare facilities, is under legal scrutiny following a class-action lawsuit that accuses the company of orchestrating …

CleanCore Solutions Announces Closing of $175,000,420 Private Placement
Establishes the official Dogecoin Treasury of the Dogecoin Foundation and its Newly Established Corporate Arm, the House of Doge The transaction consisted of marquee institutional and crypto native investors including, but not limited to, MOZAYYX, Pantera, …

Mulvihill Premium Yield Fund Declares Monthly Fund Distribution for its ETF Class
TORONTO, Sept. 05, 2025 (GLOBE NEWSWIRE) -- (TSX: MPY) Mulvihill Premium Yield Fund has declared a monthly cash distribution for its ETF Class in the amount of $0.06400 per unit, payable on October 6, 2025 to unitholders of record on September 29, 2025. …

ROSEN, A LEADING LAW FIRM, Encourages Spectrum Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – SPPI
NEW YORK, Sept. 05, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Spectrum Pharmaceuticals, Inc. (NASDAQ: SPPI) between May 12, 2022 and September 22, 2022, both dates inclusive (the …